Avantax Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Buy
107,883
+14,034
+15% +$1.56M 0.07% 233
2025
Q1
$10.5M Sell
93,849
-2,896
-3% -$324K 0.06% 235
2024
Q4
$8.94M Sell
96,745
-10,184
-10% -$941K 0.06% 256
2024
Q3
$8.96M Buy
106,929
+9,338
+10% +$783K 0.06% 246
2024
Q2
$6.7M Buy
97,591
+64,119
+192% +$4.4M 0.05% 293
2024
Q1
$2.45M Sell
33,472
-3,195
-9% -$234K 0.02% 488
2023
Q4
$2.97M Sell
36,667
-4,808
-12% -$390K 0.03% 405
2023
Q3
$3.11M Sell
41,475
-761
-2% -$57K 0.03% 351
2023
Q2
$3.26M Sell
42,236
-2,044
-5% -$158K 0.04% 336
2023
Q1
$3.67M Buy
44,280
+1,562
+4% +$130K 0.05% 305
2022
Q4
$3.67M Sell
42,718
-6,625
-13% -$569K 0.05% 283
2022
Q3
$3.04M Buy
49,343
+7,123
+17% +$439K 0.05% 292
2022
Q2
$2.61M Buy
42,220
+5,635
+15% +$348K 0.04% 325
2022
Q1
$2.18M Buy
36,585
+535
+1% +$31.9K 0.03% 356
2021
Q4
$2.62M Sell
36,050
-243
-0.7% -$17.6K 0.04% 310
2021
Q3
$2.53M Buy
36,293
+8,575
+31% +$597K 0.04% 299
2021
Q2
$1.91M Buy
27,718
+4,632
+20% +$319K 0.03% 335
2021
Q1
$1.49M Buy
23,086
+1,561
+7% +$101K 0.03% 355
2020
Q4
$1.26M Sell
21,525
-33,768
-61% -$1.97M 0.03% 354
2020
Q3
$3.48M Buy
55,293
+33,381
+152% +$2.1M 0.06% 257
2020
Q2
$1.69M Buy
21,912
+6,388
+41% +$493K 0.05% 249
2020
Q1
$1.16M Buy
15,524
+5,480
+55% +$408K 0.03% 275
2019
Q4
$650K Sell
10,044
-1,947
-16% -$126K 0.02% 413
2019
Q3
$758K Buy
11,991
+185
+2% +$11.7K 0.03% 256
2019
Q2
$798K Sell
11,806
-211
-2% -$14.3K 0.04% 225
2019
Q1
$781K Buy
12,017
+363
+3% +$23.6K 0.04% 213
2018
Q4
$729K Buy
+11,654
New +$729K 0.12% 169